Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Szépfalusi, Z; Gruber, S; Eiwegger, T; Dehlink, E (2011). Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs. European Journal of Pediatrics, 170(2):137-148.

Full text not available from this repository.

View at publisher

Abstract

Allergen-specific immunotherapy (SIT) in its various application forms represents the main treatment approach of IgE-mediated allergic diseases in adults and children. Despite this clear recommendation, many particularities of products, patient characteristics, and product availability in different countries hamper the use of allergen-specific immunotherapy in particular in children. The frequently asked questions by parents, patients, and physicians are the backbone of this review. Thus, the potentials and limitations of allergen-specific immunotherapy in children and adolescents will be highlighted. IgE-mediated allergic diseases are affecting about 20% of the population. They manifest commonly early in life, and hence, the use of SIT should be considered also early in the course of the disease.

Citations

1 citation in Web of Science®
2 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Swiss Institute of Allergy and Asthma Research
DDC:610 Medicine & health
Language:English
Date:2011
Deposited On:11 Mar 2012 13:48
Last Modified:27 Nov 2013 20:44
Publisher:Springer
ISSN:0340-6199
Publisher DOI:10.1007/s00431-010-1348-7
PubMed ID:21153032

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page